Isotopia Molecular Imaging ltd’s Post

Ananda Developments Plc (AQSE:ANA) finance director Jeremy Sturgess-Smith shares promising results from preclinical studies investigating the efficacy of MRX1 in treating cardiac fibrosis and heart failure with preserved ejection fraction (HFpEF). Sturgess-Smith explained that Ananda Developments acquired MRX Medical, the company that owns the MRX1 IP, last year. The company specialises in chronic inflammatory pain conditions and cannabis-based medicinal treatments. The study shows that dosing MRX1 in mice with heart failure and preserved ejection fraction can bring heart and lung weight back to healthy levels and significantly reduce heart failure compounds. Sturgess-Smith emphasised the high unmet medical need in treating heart failure, with limited options beyond diet and exercise. Ananda Developments aims to include MRX1 as part of its treatment portfolio, alongside its existing two Phase II trials investigating... Watch at #Proactive #ProactiveInvestors http://ow.ly/JkEF105ye5S

From groundbreaking #clinicaltrials to gaining critical #regulatoryapprovals, 2023 was a landmark year in the field of #focusedultrasound. Today, we continue to count down our "Top 10 Most Clicked News Stories" from 2023! # 9: Focused Ultrasound for Varicose Veins News: In June, Theraclion received US FDA clearance to begin a new pivotal clinical trial testing its Sonovein focused ultrasound system, a #noninvasive echotherapy treatment of #varicoseveins. The first patients were treated in the multicenter study, called VEINRESET, in October. Read the full story: https://ow.ly/vY1g50QnwRy

UPS and FedEx are not the only ones working around the clock to bring your gifts in time for Holidays! Exosomes do it all the time. This conference appears to be an interesting opportunity to discuss delivery strategies for therapeutic biomolecules! #exosomes #extracellularvesicles #rettsyndrome #endometriosis #alzheimers #alzheimersdisease

⚡ Nivolumab plus platinum-doubletchemotherapy in treatment-naive patientswith advanced grade 3 NeuroendocrineNeoplasms of gastroenteropancreatic orunknown origin: The multicenter phase 2NICE-NEC trial (GETNE-T1913) 🦓 #NeuroendocrineTumors https://buff.ly/46MiN8T

Innovations in intracranial aneurysm treatment: a pilot study on the Choydar flow diverter Frontiers https://lnkd.in/gYaN7yrn

Newly released in the DNA Educational Activities Center - DNP Volume 3 | Broadcast 3 - New Perspectives on the Management of Generalized Pustular Psoriasis, Presented by Leigh Ann Pansch, MSN, FNP-BC, DCNP The purpose of this activity is to is to provide healthcare team members a detailed overview of recent clinical trial and real-world utilization data specific to the use of therapeutics for the short- and long-term management of generalized pustular psoriasis (GPP), and an overview of some of the most common quality of life issues faced by patients with GPP. The DNP Broadcast series is available free to DNA members and non-members! https://lnkd.in/evBgU75Y #DNA #DNP #ContinuingEducation #Psoriasis #PustularPsoriasis #Broadcast #GrowthIsInOurDNA #DermNursing #Healthcare #Membership

#OrsiroMission DES significantly reduces target lesion failure in STEMI patients. Discover the BIOSTEMI-ES 5-year outcomes now 👉 https://ow.ly/KvGF50SN8Ul #BIOTRONIK #VI #DES #PCI #WhatWouldYouChoose #BIOSTEMI

Exciting news! Our phase 2 clinical trial for Long COVID, featuring valacyclovir and celecoxib, is currently in progress and we're thrilled to announce that we've already enrolled 50% of our target participants! If you're eager to join this groundbreaking study and learn more about how you can get involved, simply click the link below for further details. Let's make strides together in the fight against Long COVID! Click here: bit.ly/ValCelStudy Suzanne D. Vernon, PhD Candace Rond #LongCOVID #ExtremeFatigue #BrainFog #Pain #OrthostaticIntolerance #Dizzy #FoggyBrain #DisruptedSleep #Headache #PostViral #LongCOVIDRecovery #BeatLongCOVID #LongCOVIDClinicalTrial #LongCOVIDStudy #EnrollingNow #EnrollingStudyParticipants #ParticipateInResearch #Utah #UtahClinicalTrials #UtahResearchStudy #ClinicalTrials #valacyclovir #celecoxib #KickLongCOVID #KickCOVID

Ophthopedia Update:Reply: We appreciate Dr Schutz’s interest in our article.1 Although Dr Schutz implies that we refer to pneumatic retinopexy (PnR) as a “simple procedure” and “easy for elderly patients,” these terms were not used in our article. We did emphasize benefits of PnR in terms of faster recovery, better functional outcomes, and reduced morbidity compared with scleral buckle (SB) and pars plana vitrectomy (PPV), based on data from two randomized controlled trials.2,3 #Ophthalmology #Retina #Ophthotwitter

Discover the groundbreaking solution in biliary stricture diagnosis! One study suggested, our SpyGlass™ DS Direct Visualization system could improve costs compared to ERCP cytology brushing by reducing repeat procedures. Learn more: https://bit.ly/3VZzJp3 #BSCEMEA #HPB #Diagnosis